Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · Real-Time Price · USD

11.99

+1.21 (11.22%)

At close: Sep 4, 2026, 4:00 PM EDT

11.61

-0.38 (-3.17%)

After-hours: Sep 4, 2026, 7:45 PM EDT

Burning Rock Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	514.43	539.57	515.82	537.44	563.24	507.86
Revenue Growth	-1.69%	4.60%	-4.02%	-4.58%	10.90%	18.13%
Cost of Revenue	130.91	136.65	153.42	174.21	183.2	143.72
Gross Profit	383.52	402.91	362.4	363.23	380.04	364.15
Selling, General & Admin	288.37	291.27	452.54	685.53	938.58	793.35
Research & Development	153.66	166.49	232.29	347.02	421.87	367.86
Operating Expenses	442.03	457.76	684.83	1,033	1,360	1,161
Operating Income	-58.51	-54.85	-322.43	-669.32	-980.41	-797.06
Interest Expense	-0.05	-0.03	-	-	-	-1.54
Interest & Investment Income	6.73	8.05	12.21	17.96	9.36	3.46
Currency Exchange Gain (Loss)	-6.62	-6.71	-0.1	-0.42	1.55	-0.85
Other Non Operating Income (Expenses)	0.69	-0.26	4.71	0.48	0.25	0.2
EBT Excluding Unusual Items	-57.75	-53.79	-305.61	-651.3	-969.25	-795.8
Asset Writedown	-	-	-35.13	-	-	-
Pretax Income	-57.75	-53.79	-340.74	-651.3	-969.25	-795.8
Income Tax Expense	1.56	1.56	5.89	2.39	1.99	0.9
Net Income	-59.32	-55.35	-346.63	-653.69	-971.23	-796.7
Net Income to Common	-59.32	-55.35	-346.63	-653.69	-971.23	-796.7
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	11	11	10	10	10	10
Shares Outstanding (Diluted)	11	11	10	10	10	10
Shares Change	1.44%	3.27%	0.53%	-1.46%	-0.29%	51.83%
EPS (Basic)	-5.61	-5.21	-33.67	-63.84	-93.47	-76.45
EPS (Diluted)	-5.61	-5.21	-33.67	-63.84	-93.47	-76.45
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-39.47	-33.69	-97.68	-263.89	-527.1	-688.81
Free Cash Flow Per Share	-3.73	-3.17	-9.49	-25.77	-50.73	-66.10
Gross Margin	74.55%	74.67%	70.26%	67.58%	67.47%	71.70%
Operating Margin	-11.37%	-10.17%	-62.51%	-124.54%	-174.07%	-156.94%
Profit Margin	-11.53%	-10.26%	-67.20%	-121.63%	-172.44%	-156.87%
Free Cash Flow Margin	-7.67%	-6.24%	-18.94%	-49.10%	-93.58%	-135.63%
EBITDA	-44.33	-33.22	-271.05	-537.87	-859.66	-752.46
EBITDA Margin	-8.62%	-6.16%	-52.55%	-100.08%	-152.63%	-148.16%
D&A For EBITDA	14.18	21.62	51.39	131.45	120.75	44.6
EBIT	-58.51	-54.85	-322.43	-669.32	-980.41	-797.06
EBIT Margin	-11.37%	-10.17%	-62.51%	-124.54%	-174.07%	-156.94%
Revenue as Reported	539.57	539.57	515.82	537.44	563.24	507.86

SEC Filings: 10-K · 10-Q